Literature DB >> 27301460

Telemedicine in the management of non-acute headaches: A prospective, open-labelled non-inferiority, randomised clinical trial.

Kai I Müller1,2, Karl B Alstadhaug1,3, Svein I Bekkelund1,2.   

Abstract

Objectives We determined headache patients' satisfaction with telemedicine and assessed how telemedicine influenced headache burden, compliance with diagnosis and treatment, and need for follow-up consultations. Methods During 2.5 years, patients from Northern Norway referred with non-acute headaches for a specialist consultation at Tromsø University Hospital were consecutively randomised to either telemedicine or traditional visits. Baseline data were recorded and compared to data from a three-month follow-up questionnaire (see Supplementary material). The following were evaluated: (1) satisfaction with the consultation; (2) headache status; subjective improvement, average pain intensity, treatment, headache days per month, and Headache Impact Test (HIT-6); and (3) treatment compliance and follow-up visits. Results Out of 402 consultations, 348 (86.6%) answered the questionnaire. Satisfaction was similar in the telemedicine and the traditional group (88.8% vs. 92.3%; p = 0.35). Subgroup analyses were not prespecified, but there were no differences in satisfaction among females, migraineurs, rural patients and urban patients. Improvement from baseline after three months was reported equally in the telemedicine and the traditional groups. There were also no differences in treatment compliance, but rural telemedicine patients had less-frequent headache visits at three months' follow-up (28.9% vs. 48.7%, p = 0.002). Conclusion Telemedicine is non-inferior to traditional consultations in patient satisfaction, specialist evaluation, and treatment of non-acute headaches. ClinicalTrials.gov ID: NCT02270177.

Entities:  

Keywords:  Headache; consultation; diagnosis; management; rural; satisfaction; telemedicine; treatment

Mesh:

Year:  2016        PMID: 27301460     DOI: 10.1177/0333102416654885

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  12 in total

Review 1.  Telemedicine Applications for the Evaluation of Patients with Non-Acute Headache: A Narrative Review.

Authors:  Constantinos Dean Noutsios; Virginie Boisvert-Plante; Jordi Perez; Jonathan Hudon; Pablo Ingelmo
Journal:  J Pain Res       Date:  2021-06-01       Impact factor: 3.133

2.  Headache teleconsultation in the era of COVID-19: Patients' evaluation and future directions.

Authors:  Leonor Dias; Bárbara Martins; Maria João Pinto; Ana Luísa Rocha; Madalena Pinto; Andreia Costa
Journal:  Eur J Neurol       Date:  2021-06-09       Impact factor: 6.288

3.  A randomized trial of telemedicine efficacy and safety for nonacute headaches.

Authors:  Kai I Müller; Karl B Alstadhaug; Svein I Bekkelund
Journal:  Neurology       Date:  2017-06-14       Impact factor: 9.910

4.  Evaluation of a pilot paediatric concussion telemedicine programme for northern communities in Manitoba.

Authors:  Michael J Ellis; Susan Boles; Vickie Derksen; Brenda Dawyduk; Adam Amadu; Karen Stelmack; Matthew Kowalchuk; Kelly Russell
Journal:  Int J Circumpolar Health       Date:  2019-12       Impact factor: 1.228

5.  Video consultations in medication overuse headache. A randomized controlled trial.

Authors:  Svein I Bekkelund; Kai I Müller
Journal:  Brain Behav       Date:  2019-06-17       Impact factor: 2.708

Review 6.  Clinical and economic strategies in outpatient medical care during the COVID-19 pandemic.

Authors:  David Anthony Provenzano; B Todd Sitzman; Samuel Ambrose Florentino; Glenn A Buterbaugh
Journal:  Reg Anesth Pain Med       Date:  2020-05-31       Impact factor: 6.288

7.  Telehealth as a new care delivery model: The headache provider experience.

Authors:  Mia T Minen; Christina L Szperka; Kayla Kaplan; Annika Ehrlich; Nina Riggins; Paul Rizzoli; Lauren Doyle Strauss
Journal:  Headache       Date:  2021-07-26       Impact factor: 5.311

8.  Headache patients' satisfaction with telemedicine: a 12-month follow-up randomized non-inferiority trial.

Authors:  K I Müller; K B Alstadhaug; S I Bekkelund
Journal:  Eur J Neurol       Date:  2017-04-21       Impact factor: 6.089

9.  Managing Migraine in the Times of COVID-19 Pandemic.

Authors:  Debashish Chowdhury; Debabrata Datta
Journal:  Ann Indian Acad Neurol       Date:  2020-04-20       Impact factor: 1.383

10.  Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers.

Authors:  Christina L Szperka; Jessica Ailani; Rebecca Barmherzig; Brad C Klein; Mia T Minen; Rashmi B Halker Singh; Robert E Shapiro
Journal:  Headache       Date:  2020-04-03       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.